๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Levodopa/carbidopa and Parkinson's disease progression

Book ID
120856059
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2004
Weight
121 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Carbidopa/levodopa pharmacy errors in Pa
Carbidopa/levodopa pharmacy errors in Parkinson's disease
โœ Nasim R. Khadem; Melissa J. Nirenberg ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 958 KB

## Abstract Outpatient pharmacy errors are common, but little is known about their occurrence in Parkinson's disease (PD). We prospectively studied carbidopa/levodopa pharmacy errors in a cohort of PD outpatients. Over 1 year, pharmacy errors occurred in 8/73 (11%) subjects treated with this medica

Double-blind trial of levodopa/carbidopa
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
โœ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 443 KB

## Abstract We performed a 39โ€week, randomized, doubleโ€blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twentyโ€three patie